+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID04524585

Study of Partial Neuromuscular Blockade Using Cisatracurium to Support Safe Breathing in Adults with Moderate to Severe Acute Hypoxemic Respiratory Failure on Mechanical Ventilation or ECMO

Led by University Health Network, Toronto · Updated on 2026-01-06

23

Participants Needed

1

Research Sites

12 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new approach to managing breathing in patients with moderate to severe acute hypoxemic respiratory failure AHRF who require invasive mechanical ventilation. The study aims to assess the safety and feasibility of using partial neuromuscular blockade to allow safe spontaneous breathing while protecting the lungs. This approach may help avoid complications linked to full neuromuscular blockade commonly used in these patients. The study involves administering an infusion of the drug cisatracurium to maintain moderate inspiratory effort, measured by expiratory occlusion pressure Pocc between -5 and -15 cmH2O, after ensuring adequate sedation. The sedation and drug dosage will be adjusted to maintain these targets while monitoring respiratory comfort and muscle activity. The intervention lasts for 48 hours or until the patients hypoxemia improves to specified levels. Participants will be closely monitored during the intervention period with assessments including respiratory effort, sedation levels, hemodynamics, and safety measurements like train-of-four ratio. The main outcome is the rate of patients achieving and maintaining targeted Pocc over 48 hours. Researchers will also track serious adverse events and patient recall of paralysis after extubation. The total participation period aligns with the intervention and observation timeframe.

CONDITIONS

Brief Title

Partial Neuromuscular Blockade in Acute Hypoxemic Respiratory Failure

Research Team

G

Glauco M. Plens, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here